Abstract
There are several different imaging modalities, such as ultrasound, computed tomography, and magnetic resonance imaging, which can be used to evaluate the liver for metastatic deposits. Furthermore, there are different ways to perform each of these imaging modalities. As a result, the role and sequence of various modalities and techniques can be very confusing. In devising schemes for screening the liver for metastatic disease, the goal is to detect the presence of neoplastic foci with a high degree of certainty and consistency in a noninvasive fashion. In devising schemes for the preoperative evaluation of potential candidates for hepatic resection, the goal is to determine the number, size, and location of every metastatic deposit. Invasive techniques are acceptable in this setting, since in some instances detection of additional lesions may render a patient unresectable and unnecessary surgery will be avoided. The purpose of this discussion is to elucidate the role of various noninvasive and invasive imaging techniques for screening and evaluating the liver preoperatively for metastatic disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Dwyer A, Doppman JL, Adams AJ, Girton ME, Chernick SS, Cornblath M. 1983. Influence of glycogen on liver density: Computed tomography from a metabolic perspective. J Comput Assist Tomogr 7:70–73.
Moss AA, Dean PB, Axel L, Schrumpf J, Schnyder P, Korobkin M, Shimshak RR. 1979. Computed tomography of focal hepatic lesions: A blind clinical evaluation of the effect of contrast enhancement. Radiology 131:427–430.
Sager EM, Scheel B, Talle K. 1985. Increased detectability of liver metastases by the use of contrast enhancement in computed tomography. Acta Radiol 26:369–372.
Tidebrant G, Asztely M, Lukes P, Tylen U. 1990. Comparison of non-enhanced, bolus enhanced and delayed scanning techniques in computed tomography of hepatic tumours. Acta Radiol 31:161–166.
Bressler EL, Alpern MB, Glazer GM, Francis IR, Ensminger WD. 1987. Hypervascular hepatic metastases: CT evaluation. Radiology 162:49–51.
Kormano M, Dean PB. 1976. Extravascular contrast material: The major component of contrast enhancement. Radiology 121:379–382.
Burgener FA, Hamlin DJ. 1983. Contrast enhancement in abdominal CT: Bolus vs. infusion. AJR 140:291–295.
Heiken JP, Weyman PJ, Lee JKT, Balfe DM, Picus D, Brunt EM, Flye MW. 1989. Detection of focal hepatic masses: Prospective evaluation with CT, delayed CT, CT during arterial portography and MR imaging. Radiology 171:47–51.
Matsui O, Takashima T, Kadoya M, Suzuki M, Hirose J, Kameyama T, Choto S, Konishi H, Ida M, Yamaguchi A, Izumi R. 1987. Liver metastases from colorectal cancers: Detection with CT during arterial portography. Radiology 165:65–69.
Chezmar JL, Rumancik WM, Megibow AJ, Hulnick DH, Nelson RC, Bernardino ME. 1988. Liver and abdominal screening in patients with cancer: CT versus MR imaging. Radiology 168:43–47.
Freeny PC, Marks WM. 1986. Hepatic hemangioma: Dynamic bolus CT. AJR 147:711–719.
Ney DR, Fishman EK, Hiederhuber JE. 1991. Three-dimensional vascular imaging of the liver with spiral CT. Presented at the 77th Scientific Assembly and Annual Meeting of the Radiological Society of North America, Chicago, IL, November 1991.
Becker JA, Gregoire A, Berdon W, Schwartz D. 1968. Vicarious excretion of Urographic media. Radiology 90:243–248.
Bernardino ME, Erwin BC, Steinberg HV, Baumgartner BR, Torres WE, Gedgaudas-McClees RK. 1986. Delayed hepatic CT scanning: Increased confidence and improved detection of hepatic metastases. Radiology 159:71–74.
Nelson RC, Chezmar JL, Peterson JE, Bernardino ME. 1989. Contrast-enhanced CT of the liver and spleen: Comparison of ionic and nonionic contrast agents. AJR 153:973–976.
Stark DS, Wittenberg J, Edelman RR, Middleton MS, Saini S, Butch RJ, Brady TJ, Ferrucci JT. 1986. Detection of hepatic metastases: Analysis of pulse sequence performance in MR imaging. Radiology 159:365–370.
Foley WD, Kneeland JB, Cates JD, Kellman GM, Lawson TL, Middleton WD, Hendrick RE. 1987. Contrast optimization for the detection of focal hepatic lesions by MR imaging at 1.5 T. AJR 149:1155–1160.
Nelson RC, Chezmar JL, Sugarbaker PH, Bernardino ME. 1989. Hepatic tumors: Comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation. Radiology 172:27–34.
Vassiliades VG, Foley WD, Alarcon J, Lawson T, Erickson S, Kneeland JB, Steinberg HV, Bernardino ME. 1991. Hepatic metastases: CT versus MR imaging at 1.5 T. Gastrointest Radiol 16:159–163.
Rummeny EJ, Wernecke K, Saini S, Vassallo P, Weismann W, Oestmann JW, Kivelitz D, Reers B, Reiser MF, Peters PE. 1992. Comparison between high-field-strength MR imaging and CT for screening of hepatic metastases: A receiver operating characteristic analysis. Radiology 182:879–886.
Semelka RC, Shoenut JP, Kroeker MA, Greenberg HM, Simm FC, Minuk GY, Kroeker RM, Micflikier AB. 1992. Focal liver disease: Comparison of dynamic contrast-enhanced CT and T2-weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T. Radiology 184:687–694.
Stark DD, Felder RC, Wittenberg J, Saini S, Butch RJ, White ME, Edelman RR, Mueller PR, Simeone JF, Cohen AM, Brady TJ, Ferrucci JT. 1985. Magnetic resonance imaging of cavernous hemangioma of the liver: Tissue-specific characterization. AJR 145:213–222.
Mattison GR, Glazer GM, Quint LE, Francis IR, Bree RL, Ensminger WD. 1987. MR imaging of hepatic focal nodular hyperplasia: Characterization and distinction from primary malignant hepatic tumors. AJR 148:711–715.
Ohtomo K, Itai Y, Yoshikawa K, Kokubo T, Yashiro N, Iio M, Furukawa K. 1987. Hepatic tumors: Dynamic MR imaging. Radiology 163:27–31.
Nelson RC, Chezmar JL, Newberry LB, Malko JA, Gedgaudas-McClees RK, Bernardino ME. 1991. Manganese dipyridoxal diphosphate: Effect of dose, time and pulse sequence on hepatic enhancement in rats. Invest Radiol 26:569–673.
Hamm B, Vogl TJ, Branding G, Schnell B, Taupitz M, Wolf K-J, Lessner J. 1992. Focal liver lesions: MR imaging with Mn-DPDP — initial clinical results in 40 patients. Radiology 182:167–174.
Stark DD, Weissleder R, Elizondo G, Hahn PF, Saini S, Todd LE, Wittenberg J, Ferrucci JT. 1988. Superparamagnetic iron oxide: Clinical application as a contrast agent for MR imaging of the liver. Radiology 168:297–301.
Matsui O, Takashima T, Kadoya M, Ida M, Suzuki M, Kitagawa K, Inoue K, Konishi H, Itoh H. 1985. Dynamic computed tomography during arterial portography: The most sensitive examination for small hepatocellular carcinomas. J Comput Assist Tomogr 9:19–24.
Dodd GD, Miller WJ, Baron RL, Skolnick ML, Campbell WL. 1992. Detection of malignant tumors in end-stage cirrhotic livers: Efficacy of sonography as a screening technique. AJR 159:727–733.
Ackerman NB, Lien WM, Kondi ES, Silverman NA. 1969. The blood supply of experimental liver metastases: I. Distribution of hepatic artery and portal vein blood to’ small’ and ‘large’ tumors. Surgery 66:1067–1072.
Freeny PC, Marks WM. 1986. Hepatic perfusion abnormalities during CT angiography: Detection and interpretation. Radiology 159:685–691.
Nelson RC, Thompson GH, Chezmar JL, Harned RK, Fernandez MP. 1992. CT during arterial portography: Diagnostic pitfalls. Radiographics 12:705–718.
Sugarbaker PH, Nelson RC, Murray DR, Chezmar JL, Bernardino ME. 1990. A segmental approach to computerized tomographic portography for hepatic resection. Surg Gynecol Obstet 171:189–195.
Nelson RC, Chezmar JL, Sugarbaker PH, Murray DR, Bernardino ME. 1990. Preoperative localization for focal liver lesions to specific liver segments: Utility of CT during arterial portography. Radiology 176:89–94.
Soyer P, Roche A, Gad M, Shapeero L, Breittmayer F, Elias D, Lasser P, Rougier P, Levesque M. 1991. Preoperative segmental localization of hepatic metastases: Utility of three-dimensional CT during arterial portography. Radiology 180:653–658.
Igawa S, Sakai K, Kinoshita H, Hirohashi K. 1985. Intraoperative sonography: Clinical usefulness in liver surgery. Radiology 156:473–478.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Nelson, R.C. (1994). Radiological evaluation of metastases to the liver: The Emory Experience . In: Sugarbaker, P.H. (eds) Hepatobiliary Cancer. Cancer Treatment and Research, vol 69. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2604-9_13
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2604-9_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6115-2
Online ISBN: 978-1-4615-2604-9
eBook Packages: Springer Book Archive